☆ 4.7 Article

Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Related references

Note: Only part of the references are listed.

Article Otorhinolaryngology

Management of new onset loss of sense of smell during the COVID-19 pandemic - BRS Consensus Guidelines

Claire Hopkins et al.

Summary: This study aims to provide recommendations for the investigation and management of patients with new onset loss of sense of smell during the COVID-19 pandemic. A panel of 15 experts used the RAND/UCLA methodology to reach consensus on treatment options, referral guidelines, and imaging. Consensus was achieved on most statements after 2 rounds of ranking, with olfactory training recommended for all patients with persistent loss of sense of smell, and individual consideration for oral steroids, steroid rinses, and omega 3 supplements.

CLINICAL OTOLARYNGOLOGY (2021)

Add to Collection

Article Otorhinolaryngology

Efficacy of corticosteroid therapy in the treatment of long-lasting olfactory disorders in COVID-19 patients

Luigi Angelo Vaira et al.

Summary: This study involving 18 COVID-19 patients with olfactory disorders found that a treatment regimen including steroids resulted in significant improvements in olfactory function compared to untreated controls. The findings suggest that this specific therapy may be useful in reducing the prevalence of long-term olfactory morbidity.

RHINOLOGY (2021)

Add to Collection

Article Otorhinolaryngology

Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial

Abdelrahman Ahmed Abdelalim et al.

Summary: The study found that using mometasone furoate nasal spray as a topical corticosteroid for post COVID-19 anosmia did not offer significant benefits over olfactory training, with no statistical differences in treatment outcomes and recovery rates.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Add to Collection

Article Otorhinolaryngology

The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients

Chandra Veer Singh et al.

Summary: The study demonstrated that the use of fluticasone nasal spray and triamcinolone paste significantly improved olfactory and taste function in COVID-19 patients, with faster recovery compared to the control group.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Add to Collection

Article Otorhinolaryngology

Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: an international view

Caroline Huart et al.

Summary: The frequent association between COVID-19 and olfactory dysfunction is leading to a demand for treatment, with systemic corticosteroids considered as an option. However, caution is advised due to weak evidence supporting their effectiveness, high rate of spontaneous recovery, and potential adverse effects. Instead, smell training, which has strong evidence and no known side effects, should be considered initially.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Olfactory Dysfunction in COVID-19 Diagnosis and Management

Katherine Lisa Whitcroft et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Otorhinolaryngology

Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study

Claire Hopkins et al.

JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2020)

Add to Collection

Article Otorhinolaryngology

Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19

Paolo Boscolo-Rizzo et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2020)

Add to Collection

Article Otorhinolaryngology

Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study

L. A. Vaira et al.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell

Jerome R. Lechien et al.

FRONTIERS IN MEDICINE (2020)

Add to Collection

Letter Otorhinolaryngology

Comparison of COVID-19 and common cold chemosensory dysfunction

C. Huart et al.

RHINOLOGY (2020)

Add to Collection

Article Food Science & Technology

Iran Smell Identification Test (Iran-SIT): a Modified Version of the University of Pennsylvania Smell Identification Test (UPSIT) for Iranian Population

Safa Taherkhani et al.

CHEMOSENSORY PERCEPTION (2015)

Add to Collection

Article Otorhinolaryngology

Treatment of Postviral Olfactory Loss With Glucocorticoids, Ginkgo biloba, and Mometasone Nasal Spray

Beom Seok Seo et al.

ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2009)

Add to Collection

Article Medicine, Research & Experimental

Effects of Olfactory Training in Patients with Olfactory Loss

Thomas Hummel et al.

LARYNGOSCOPE (2009)

Add to Collection

Article Otorhinolaryngology

Local and systemic administration of corticosteroids in the treatment of olfactory loss

S Heilmann et al.

AMERICAN JOURNAL OF RHINOLOGY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.